The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
By far the best value to watch all the on-demand educational sessions from the 2024 AABB Annual Meeting and earn continuing education credit…
Advances in molecular techniques for Red Blood Cell (RBC) genotyping and phenotyping are improving blood transfusion compatibility significantly for Sickle Cell Disease (SCD) patients and others requiring chronic transfusions. This marks a major milestone in transfusion medicine, offering improved patient-donor matching and better outcomes, while it introduces informatics challenges in using patient genotyping information for donor unit selection from inventory. Expanded RBC phenotyping data—which covers over 1,500 genomic features across more than 40 blood group systems—requires sophisticated data management in Electronic Health Records (EHRs), Blood Bank Laboratory Information Systems (BBLIS), and Blood Establishment Computer Systems (BECS). The current systems used by both hospital blood banks and donor centers do not support this level of substantive interoperability. Improving the informatics surrounding expanded phenotyping and genotyping can amplify the benefits of these molecular approaches and drive increased usage. This presentation will use case studies of SCD patients to highlight the benefits of expanded phenotypes in identifying donor units and expose informatics challenges in integrating and sharing this data. It will outline practical solutions for immediate use and future improvements, with an emphasis on standardized vocabulary, shared semantics, interoperability, and the application of machine learning/artificial intelligence for enhanced donor-patient matching. Collaborative innovation in informatics and standardized practices will establish the foundation for the full potential of molecular genotyping. This talk will guide transfusion medicine professionals in navigating these complexities and ensuring that technological progress in genotyping translates into clinical benefits for patients.
Learning Objectives
Evaluate the benefits of using genotyping information to better select RBC donor units in select patient populations.
Assess the informatics differences in how the EHR, BBLIS, and BECS may represent genotyping information, and how these differences impair interoperability of genotyping information between health systems and blood supplier.
Utilize case studies to understand the impact of matching donors for SCD patients.
Propose practical solutions for overcoming informatics obstacles in supporting genotyping information, focusing on short term incorporation of genotyping information into your BBLIS, and longer term supporting developing interoperability standards.
Evaluate innovative approaches to improve the utilization of molecular genotyping in RBC transfusions.
All relevant financial relationships have been mitigated.
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
Credits Available
Purchasing this session will automatically provide ownership of all the individually purchasable attached CE products, regardless of their stated individual purchase restrictions.
AM24-ST-07-O: Preparing for the Data Deluge: Mitigating the Informatics Challenges of Expanded RBC Genotyping Data (Enduring) Evaluation
Many common causes of type discrepancies, such as A subgroups, cold-reactive antibodies, and excess serum protein are well-described in literature and well-taught in curricula…
Malaria is caused by intra erythrocytic parasites from the genus Plasmodium. In the natural world, Plasmodium is transmitted to humans via the bite of an infected female Anopheles mosquito…